Parker Group's Project: AVenue
In a bid to address the growing threat posed by cellular signal jammers, Digital Media Projects (DMP) has introduced JamAlert. This device is designed to detect illegal cellular jammers, which leave security systems vulnerable as their usage increases.
JamAlert operates over the IT infrastructure, working to ensure that vital communication channels remain uninterrupted. The device captures and decodes AV signals from AVenue, DMP's AV over IP solution for recording and distributing critical enterprise business content.
AVenue empowers users to leverage captured data, sending high-resolution AV content securely over the IT infrastructure to Digital Media Servers (DMS). These servers record incoming AV streams and share them in real-time with remote hardware and software, allowing viewers to watch them remotely.
The recorded AV files from AVenue can be played back for analysis, engineering, reviews, and training purposes. AVenue also supports global control rooms and mission-critical environments, capturing, sharing, recording, storing, and replaying crucial situation-awareness content.
The threat of cellular signal jammers necessitates the introduction of detection devices like JamAlert. These jammers pose a significant risk to security systems, making it essential to have a solution in place.
In addition to JamAlert, the manufacturer of the AV-Over-IP solution AVenue is not explicitly stated in the provided search results. However, it is clear that AVenue is an essential component in the fight against cellular signal jammers, providing up-to-the-minute information for users.
The introduction of JamAlert aims to combat the growing threat of cellular signal jammers, ensuring that businesses and security systems remain protected in an increasingly connected world.
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- House Infernos: Deadly Hazards Surpassing the Flames
- Aspergillosis: Recognizing Symptoms, Treatment Methods, and Knowing When Medical Attention is Required
- Biomarkers as potential indicators in guiding treatment for ulcerative colitis?